Patent · US Active

Delivery system for heparin-binding growth factors

US7875591B2 · kind B2 · utility

1Cited by
5References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 22, 2009
Grant dateJan 25, 2011
Priority date
Expiry dateJul 18, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/414
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A device comprising a scaffold coated with a protein having at least 83% identity to the amino acid sequence of the core protein of domain I of a mammalian perlecan, wherein at least one glycosaminoglycan is attached to the protein is described. The device may be used in vitro or in vivo to induce replication and/or differentiation of connective tissue cells and to repair tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.